Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Glioblastoma
Interventions: DRUG: Sacituzumab Govitecan
Sponsor: The University of Texas Health Science Center at San Antonio
Collaborators: Gilead Sciences